Gold falters on vaccine progress – Charles Schwab

FXStreet Team FXStreet

Gold futures recent loss of luster continued on Thursday as investors weighed reported progress on multiple COVID-19 vaccines. The yellow metal had experienced a tremendous rally from the initial March 1450 pandemic low to the near 2100 August highs but the market has since consolidated wrapped around the 1900 mark while the December Gold contract (GC20) has drifted back down to test the 1850 low end of its recent price range. With the election in the rearview mirror and stimulus talks on the back burner, daily pandemic news continues to be front and center, Joe Schulte from Charles Schwab briefs.

Key quotes

“After last week’s positive Pfizer study, Moderna reported encouraging results of their own this week. Progress on the vaccine front has precious metals on the defensive as the potential for an eventual return to economic stability and growth erodes the safe-haven attraction.”

“Profit-taking, and a surging equity market, have seen metal prices stagnate. Outflows of money from gold exchange-traded funds and into other sectors has continued to track in recent weeks.”

“Despite the encouraging vaccine trials for the future, the recent troubling spike in infections at home and abroad has raised more immediate concerns. Infections have surpassed 55 million globally with over 1.3 million deaths. Here in the US and in Europe, we have seen a return of lockdown measures to combat the spread. Any resumption of extended lockdowns, and their resulting drag on economic activity, will be supportive to gold until the vaccines become a reality.”

“The US Dollar’s woes continues to offer some support to gold with the US Dollar Index slipping back to test the 92.00 support level again this week.”

“First support will be encountered at the 1848 level. A move below that mark will then have the 1806 200-day moving average in sight. Rebounds will find first resistance at 1884 and 1898. Longer-term resistance will be found at the 1966 high posted a week ago Monday. The 14-day RSI bears watching as the reading has slipped to 43.”

Author

FXStreet Team

FXStreet

EUR/USD stays below 1.1850 after dismal German sentiment data

EUR/USD stays in negative territory below 1.1850 in the second half of the day on Tuesday. Renewed US Dollar strength, combined with a softer risk tone keep the pair undermined alongside downbeat German ZEW sentiment readings for February.

GBP/USD falls toward 1.3550, pressured by weak UK jobs report

GBP/USD remains under bearish pressure and extends its decline below 1.3600 on Tuesday. The United Kingdom employment data suggested worsening labor market conditions, bolstering bets for a BoE interest rate cut next month and making it difficult for Pound Sterling to stay resilient against its peers.

Gold recovers modestly, stays deep in red below $4,950

Gold (XAU/USD) stages a rebound but remains deep in negative territory below $4,950 after touching its weakest level in over a week near $4,850 earlier in the day. Renewed US Dollar strength makes it difficult for XAU/USD to gather recovery momentum despite the risk-averse market atmosphere.

Canada CPI expected to show sticky inflation in January, still above BoC’s target

Economists see the headline CPI rising by 2.4% in a year to January, still above the BoC’s target and matching December’s increase. On a monthly basis, prices are expected to rise by 0.1%.

UK jobs market weakens, bolstering rate cut hopes

In the UK, the latest jobs report made for difficult reading. Nonetheless, this represents yet another reminder for the Bank of England that they need to act swiftly given the collapse in inflation expected over the coming months.

Stellar mixed sentiment caps recovery

Stellar price remains under pressure, trading at $0.170 on Tuesday after failing to close above the key resistance on Sunday. The derivatives metric supports the bearish sentiment, with XLM’s short bets rising among traders and funding rates turning negative.